The biological effects of tocotrienol on bone: a review on evidence from rodent models
- PMID: 25897211
- PMCID: PMC4396581
- DOI: 10.2147/DDDT.S79660
The biological effects of tocotrienol on bone: a review on evidence from rodent models
Abstract
Osteoporosis causes significant health care and economic burden to society, leading to a relentless search for effective preventive agents. Tocotrienol, a member of the vitamin E family, has demonstrated promising potential as an osteoporosis-preventing agent. This review summarizes evidence on the effects of tocotrienol on bone in animal models. Techniques used to examine the effects of tocotrienol on bone in animals included bone histomorphometry, X-ray microtomography, dual-energy X-ray absorptiometry, bone turnover markers, bone calcium content, and biomechanical strength. Tocotrienol was shown to improve osteoblast number, bone formation, mineral deposition, and bone microarchitecture in osteopenic rats. It also decreased osteoclast number and bone erosion in the rats. Tocotrienol supplementation resulted in an improvement in bone mineral density, although biomechanical strength was not significantly altered in the rats. The beneficial effects of tocotrienol on bone can be attributed to its role as an antioxidant, anti-inflammatory agent, suppressor of the mevalonate pathway, and modulator of genes favorable to bone formation.
Keywords: bone; osteoporosis; tocotrienol; vitamin E.
Figures
Similar articles
-
The Effects of Annatto Tocotrienol on Bone Biomechanical Strength and Bone Calcium Content in an Animal Model of Osteoporosis Due to Testosterone Deficiency.Nutrients. 2016 Dec 14;8(12):808. doi: 10.3390/nu8120808. Nutrients. 2016. PMID: 27983628 Free PMC article.
-
Effect of tocotrienol from Bixa orellana (annatto) on bone microstructure, calcium content, and biomechanical strength in a model of male osteoporosis induced by buserelin.Drug Des Devel Ther. 2018 Mar 16;12:555-564. doi: 10.2147/DDDT.S158410. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29588572 Free PMC article.
-
Effects of Calcium and Annatto Tocotrienol Supplementation on Bone Loss Induced by Pantoprazole in Male Rats.Drug Des Devel Ther. 2020 Jul 2;14:2561-2572. doi: 10.2147/DDDT.S260565. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32753839 Free PMC article.
-
Tocotrienol and Its Role in Chronic Diseases.Adv Exp Med Biol. 2016;928:97-130. doi: 10.1007/978-3-319-41334-1_5. Adv Exp Med Biol. 2016. PMID: 27671814 Review.
-
A review of the possible mechanisms of action of tocotrienol - a potential antiosteoporotic agent.Curr Drug Targets. 2013 Dec;14(13):1533-41. doi: 10.2174/13894501113149990178. Curr Drug Targets. 2013. PMID: 23859472 Review.
Cited by
-
A Review on the Relationship between Tocotrienol and Alzheimer Disease.Nutrients. 2018 Jul 9;10(7):881. doi: 10.3390/nu10070881. Nutrients. 2018. PMID: 29987193 Free PMC article. Review.
-
Tocotrienol in the Treatment of Topical Wounds: Recent Updates.Pharmaceutics. 2022 Nov 16;14(11):2479. doi: 10.3390/pharmaceutics14112479. Pharmaceutics. 2022. PMID: 36432670 Free PMC article. Review.
-
The Effects of Annatto Tocotrienol Supplementation on Cartilage and Subchondral Bone in an Animal Model of Osteoarthritis Induced by Monosodium Iodoacetate.Int J Environ Res Public Health. 2019 Aug 13;16(16):2897. doi: 10.3390/ijerph16162897. Int J Environ Res Public Health. 2019. PMID: 31412648 Free PMC article.
-
The Role of Vitamin E in Preventing and Treating Osteoarthritis - A Review of the Current Evidence.Front Pharmacol. 2018 Aug 21;9:946. doi: 10.3389/fphar.2018.00946. eCollection 2018. Front Pharmacol. 2018. PMID: 30186176 Free PMC article. Review.
-
The Role of Tocotrienol in Preventing Male Osteoporosis-A Review of Current Evidence.Int J Mol Sci. 2019 Mar 18;20(6):1355. doi: 10.3390/ijms20061355. Int J Mol Sci. 2019. PMID: 30889819 Free PMC article. Review.
References
-
- Jilka RL. Biology of the basic multicellular unit and the pathophysiology of osteoporosis. Med Pediatr Oncol. 2003;41(3):182–185. - PubMed
-
- Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733. - PubMed
-
- Kanis JA, Melton LJ, 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–1141. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources